
CJC-1295 DAC
Long-Acting GHRH Analogue

GHRH (1-29)
Order before 12:00 on a working day and it ships today
Figures above are the release specification. The certificate shipped with your vial carries the measured values for that specific lot. Email [email protected] with an order number for the raw chromatogram.
When Andrew Schally and Roger Guillemin shared the 1977 Nobel for unpicking the hypothalamic releasing factors, the full growth hormone-releasing hormone they were chasing turned out to be a 44-residue peptide. Lab work through the 1980s then asked an obvious question: how much of that chain is actually needed to fire the somatotroph? The answer, after dozens of truncation studies, was the first 29 residues from the N-terminus. Sermorelin is exactly that fragment, acetate salt, synthetic.
In pituitary cell assays the 1-29 sequence keeps essentially all of the GHRH receptor binding affinity and cAMP signalling of the full 44-mer. The trailing residues turn out to be structural padding rather than active site. That is why researchers reach for Sermorelin when they want a clean GHRH agonist without the synthesis cost or storage headache of the parent peptide.
This compound sits on the GHRH receptor only. It is not interchangeable with Ipamorelin, GHRP-2, GHRP-6, hexarelin or any of the ghrelin pathway agonists, even though all of them end up pushing GH release through the somatotroph. Different receptor, different intracellular cascade, different desensitisation profile. That distinction is the entire reason Sermorelin remains the reference compound in dual-pathway studies.
Serono brought sermorelin acetate to market in 1997 as Geref, used clinically as a diagnostic probe for paediatric GH deficiency. The product was withdrawn in 2008, not for safety reasons but because the commercial niche dried up once recombinant GH became the standard diagnostic and treatment route. The synthesis is well understood and the reference data from that clinical era still anchors modern research papers.
Material is sourced from UK and EU synthesis partners and held in our Hertfordshire facility. Roughly nine in ten UK orders land inside 48 hours, tracked. The CoA matching your vial batch sits with the listing as a PDF, and if the lab work flags anything off-spec we refund without arguing the point. Bulk orders of ten vials or more go through the support inbox so we can quote on the actual batch sitting in the freezer that week. Live chat is staffed by people who know the catalogue during UK working hours.
Sold strictly for in vitro laboratory research. Not for human or veterinary use. UK 18+.
Yes. Sermorelin can be bought and sold in the UK as a research chemical for laboratory use only. It is not a controlled substance and possession is not an offence. What is not permitted is supplying or marketing it for human consumption, which would require MHRA approval. Every vial we ship is labelled and sold strictly for in-vitro research, not for use in or on the body.
We dispatch from UK stock, and most orders placed on a working day go out same day, so the majority arrive inside 48 hours on a tracked service. Lyophilised Sermorelin is stable at ambient temperature for the short transit window, so it ships without cold packs. On arrival, move the sealed vial to a freezer until you reconstitute it for a study.
The CoA carries two tests that answer two different questions. HPLC measures purity, the percentage of the sample that is the target peptide versus truncated or deletion by-products, and ours runs above 97%. Mass spectrometry confirms identity by matching the measured mass to the expected 3357.93 g/mol, so you know it is the GHRH 1-29 sequence and not a near-miss. Purity without an MS check is only half the story.
Sermorelin is a synthetic 29-amino-acid peptide matching the N-terminal 1-29 region of human growth hormone-releasing hormone (GHRH). That fragment is the shortest portion of GHRH that retains full activity at the receptor. Published in-vitro and animal work has looked at how it stimulates pituitary somatotrophs to release growth hormone, and at the pulsatile signalling of the hypothalamic-pituitary axis. Sold for that research context only.
Store the lyophilised powder away from light, ideally frozen, where it stays stable for long periods. For laboratory handling it is typically reconstituted with bacteriostatic or sterile water added gently down the vial wall, not injected onto the pellet. Sermorelin is one of the less stable peptides once in solution, so researchers keep reconstituted material refrigerated, use it promptly, and avoid repeated freeze-thaw cycles that degrade the peptide.
The full sequence is Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg, supplied as the acetate salt and lyophilised. CAS 86168-78-7, molecular formula C149H246N44O42S, mass 3357.93 g/mol. It carries no enzyme-resistant modifications, which is why the reported plasma half-life in the published literature is short, under about 20 minutes.

Long-Acting GHRH Analogue

short-acting GHRH

